Maxim analyst Jason McCarthy upgraded Dare Bioscience (DARE) to Buy from Hold with an $8 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DARE:
- Daré Bioscience Engages Market with New Presentation
- Daré Bioscience’s Earnings Call: Optimism Amid Challenges
- Daré Bioscience: Strategic Growth and Market Expansion with Upcoming Sildenafil Cream Launch
- Daré Bioscience Announces Q2 2025 Financial Results
- Dare Bioscience, Rosy Wellness launch first phase to support DARE to PLAY